BRIEF-Halozyme's PEGPH20 increases immune response, effectiveness of immunotherapies in preclinical cancer models
April 03, 2017 at 08:19 AM EDT
* Halozyme's PEGPH20 increases immune response and effectiveness of immunotherapies in preclinical cancer models